ロード中...
Uptake of exemestane chemoprevention in postmenopausal women at increased risk for breast cancer
Despite their efficacy, uptake of selective estrogen receptor modulators for breast cancer chemoprevention remains low. Exemestane, an aromatase inhibitor, has recently been identified as a potential chemopreventive option with fewer serious side effects compared with selective estrogen receptor mod...
保存先:
| 出版年: | Eur J Cancer Prev |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Lippincott Williams & Wilkins
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4885537/ https://ncbi.nlm.nih.gov/pubmed/25642790 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CEJ.0000000000000124 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|